Capsaicin Topical Creams / Patches Suppliers & Bulk Manufacturers
Available Forms: Topical Creams / Patches
Available Strengths: 0.025%, 0.075%, 0.1%, 1%
Reference Brands: Zostrix(US)
Category:
Analgesic
Capsaicin topical creams and patches activate TRPV1 receptors on nerve endings, causing a temporary pain-sensation and depleting substance P, which reduces pain signals over time. Benefits include targeted relief from neuropathic and musculoskeletal pain, improved mobility, minimal systemic side effects, and effective long-term pain management when used as directed.
Capsaicin Topical Creams / Patches is available in Topical Creams / Patches
and strengths such as 0.025%, 0.075%, 0.1%, 1%.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Capsaicin Topical Creams / Patches is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Capsaicin Topical Creams / Patches can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Capsaicin topical creams and patches are approved in the EU and US for localized neuropathic and musculoskeletal pain. In the EU, brands like Qutenza and generic formulations are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data; products like Qutenza (8%) are registered and regulated accordingly. Both regions enforce strict controls, proper labeling, and usage guidelines to ensure safety and efficacy, especially given the potential for skin irritation. For regulatory dossier preparation, compliance, and registration support, visit PharmaTradz. We facilitate seamless market access for capsaicin topical products, adhering to European and American standards.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing